Prospective Melanoma Database
NCT02884362
Summary
In research on melanoma, translational research is the essential link between basic research and clinical research by facilitating the passage between discovery and improvement in the quality of patients care.That is the reason why it is very important to collect, and centralize clinical and biological data of patients with melanoma. The aim of the project is to provide to scientific community a structured, mixed clinical and biological database, unique in France, in order to insure accessibility to clinical data.
Eligibility
Inclusion Criteria: * Age \> 18 years * Histologically confirmed melanoma of any stage * Affiliated to a social security system in france * Who signed the informed consent Exclusion Criteria: * Any psychiatric or medical condition that would make the patient unable to give a signed informed consent
Conditions2
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT02884362